Literature DB >> 17126835

Role of microglia in the pathogenesis of osmotic-induced demyelination.

Seiko Takefuji1, Takashi Murase, Yoshihisa Sugimura, Yoshiko Takagishi, Shizu Hayasaka, Yutaka Oiso, Yoshiharu Murata.   

Abstract

Osmotic demyelination is a serious disease caused by rapid correction of hyponatremia. In humans, demyelinative lesions occur preferentially in the central pons, and thus are termed central pontine myelinolysis. Although accumulation of microglia has been reported in such demyelinative lesions, their role in the pathogenesis of osmotic demyelination remains unclear. We examined the expression of cytokines in microglia that accumulated in the demyelinative lesions in a rat model of osmotic demyelination. Hyponatremia was induced in rats by a combination of dDAVP infusion and liquid diet feeding. After 7 days, serum sodium levels were rapidly corrected by hypertonic saline injection. The rats developed severe motor deficits, and marked demyelinative lesions were found in the midbrain and cerebral cortex. In the area of the demyelinative lesions, massive accumulations of microglia were observed that expressed the proinflammatory cytokines TNF-alpha and IFN-gamma as well as iNOS. In contrast, in hyponatremia corrected rats treated with lovastatin, which is known to inhibit microglial infiltration in various animal models of CNS disease, neurological impairments and the degree of demyelination were significantly ameliorated. Lovastatin also reduced the accumulation of microglia and decreased the expression of TNF-alpha in the demyelinative lesions. These results indicate that microglia play a detrimental role in the pathogenesis of osmotic demyelination by producing proinflammatory cytokines, and further suggest that lovastatin may be useful in repressing the demyelination.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17126835     DOI: 10.1016/j.expneurol.2006.09.025

Source DB:  PubMed          Journal:  Exp Neurol        ISSN: 0014-4886            Impact factor:   5.330


  14 in total

1.  Minocycline prevents osmotic demyelination syndrome by inhibiting the activation of microglia.

Authors:  Haruyuki Suzuki; Yoshihisa Sugimura; Shintaro Iwama; Hiromi Suzuki; Ozaki Nobuaki; Hiroshi Nagasaki; Hiroshi Arima; Makoto Sawada; Yutaka Oiso
Journal:  J Am Soc Nephrol       Date:  2010-10-28       Impact factor: 10.121

2.  Astrocytes are an early target in osmotic demyelination syndrome.

Authors:  Fabrice Gankam Kengne; Charles Nicaise; Alain Soupart; Alain Boom; Johan Schiettecatte; Roland Pochet; Jean Pierre Brion; Guy Decaux
Journal:  J Am Soc Nephrol       Date:  2011-09-01       Impact factor: 10.121

3.  Minocycline protects against neurologic complications of rapid correction of hyponatremia.

Authors:  Fabrice Gankam-Kengne; Alain Soupart; Roland Pochet; Jean Pierre Brion; Guy Decaux
Journal:  J Am Soc Nephrol       Date:  2010-11-04       Impact factor: 10.121

4.  Prevention of neural tube defects by loss of function of inducible nitric oxide synthase in fetuses of a mouse model of streptozotocin-induced diabetes.

Authors:  Y Sugimura; T Murase; K Oyama; A Uchida; N Sato; S Hayasaka; Y Kano; Y Takagishi; Y Hayashi; Y Oiso; Y Murata
Journal:  Diabetologia       Date:  2009-03-13       Impact factor: 10.122

Review 5.  Human alcohol-related neuropathology.

Authors:  Suzanne M de la Monte; Jillian J Kril
Journal:  Acta Neuropathol       Date:  2013-12-27       Impact factor: 17.088

6.  Evidence of aquaporin involvement in human central pontine myelinolysis.

Authors:  Bogdan F Gh Popescu; Reem F Bunyan; Yong Guo; Joseph E Parisi; Vanda A Lennon; Claudia F Lucchinetti
Journal:  Acta Neuropathol Commun       Date:  2013-07-25       Impact factor: 7.801

7.  Acute Psychosis as Main Manifestation of Central Pontine Myelinolysis.

Authors:  Mangala Gopal; Melvin Parasram; Harsh Patel; Chike Ilorah; Hrachya Nersesyan
Journal:  Case Rep Neurol Med       Date:  2017-03-14

8.  Hyponatremia in the intensive care unit: How to avoid a Zugzwang situation?

Authors:  Cédric Rafat; Martin Flamant; Stéphane Gaudry; Emmanuelle Vidal-Petiot; Jean-Damien Ricard; Didier Dreyfuss
Journal:  Ann Intensive Care       Date:  2015-11-09       Impact factor: 6.925

9.  15d-PGJ2 Reduced Microglia Activation and Alleviated Neurological Deficit of Ischemic Reperfusion in Diabetic Rat Model.

Authors:  Lihong Huang; Gang Li; Xiaofang Feng; Luojun Wang
Journal:  Biomed Res Int       Date:  2015-12-30       Impact factor: 3.411

Review 10.  Hyponatremia and the Brain.

Authors:  Fabrice Gankam Kengne; Guy Decaux
Journal:  Kidney Int Rep       Date:  2017-09-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.